.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Novartis
Merck
Fuji
Express Scripts
QuintilesIMS
UBS
Cipla
McKinsey

Generated: February 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 102 27 232

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis UsLANTUSinsulin glargine recombinantINJECTABLE;INJECTION021081-001Apr 20, 2000RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist